Cardiology, Surgery. Development-stage company that offers a minimally invasive solution for the approximately 850,000 patients at high risk of sudden cardiac arrest. The company’s device is a subcutaneous implant that can be positioned without any imaging equipment, being placed by simple use of anatomical landmarks, and serves as a defibrillator that maintains heart activity. After receiving CE Mark approval in June 2009, the company plans to launch its product in select markets in summer 2009. Founded: 2001.